Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05132309Completed

Intestinal Microbiota Composition in Patients With Chronic Pancreatitis and Pancreatic Exocrine Insufficiency

Role: lead

NCT04611841Unknown

Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2

Role: lead

NCT04579263Not ApplicableCompleted

Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT)

Role: lead

NCT04011943Not ApplicableUnknown

Fecal Microbiota Transplantation for Health Improvement (TFM3)

Role: lead

All 4 trials loaded